RGX-121: AN INVESTIGATIONAL GENE THERAPY FOR THE TREATMENT OF NEURONOPATHIC MUCOPOLYSACCHARIDOSIS TYPE II (MPS II): INTERIM ANALYSIS OF DATA FROM THE FIRST-IN-HUMAN STUDY

被引：0
|
作者：
Blair, D. R. [1 ,2 ]
Harmatz, P. [2 ]
Ficicioglu, C. [3 ]
Giugliani, R. [4 ]
Rajan, D. S. [5 ]
Hagood, J. [6 ]
Fiscella, M. [6 ]
Yang, L. [6 ]
Gilmor, M. [6 ]
Cho, Y. [6 ]
Mulatya, C. [6 ]
Phillips, D. [6 ]
Falabella, P. [6 ]
Pisani, L. [6 ]
机构：
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
[2] UCSF Benioff Childrens Hosp Oakland, Oakland, CA USA
[3] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA
[4] HCPA, Porto Alegre, RS, Brazil
[5] Univ Pittsburgh, Pittsburgh, PA USA
[6] REGENXBIO Inc, Rockville, MD USA
来源：
JOURNAL OF INVESTIGATIVE MEDICINE | 2024年 / 72卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
566
引用
收藏
页码：638 / 638
页数：1
相关论文
共 50 条
  • [1] RGX-121 Gene Therapy for the Treatment of Neuronopathic Mucopolysaccharidosis Type II (MPS II): Interim Analysis of Data from the First in Human Study
    Harmatz, Paul
    Ficicioglu, Can
    Giugliani, Roberto
    Rajan, Deepa
    Hagood, Joseph
    Fiscella, Michele
    Yang, Lin
    Gilmor, Michelle
    Cho, Yoonjin
    Phillips, Dawn
    Pisani, Laura
    Falabella, Paulo
    MOLECULAR THERAPY, 2023, 31 (04) : 398 - 398
  • [2] RGX-121: An Investigational Gene Therapy for the Treatment of Neuronopathic Mucopolysaccharidosis Type II (MPSII): Interim Analysis from the First-in-Human Study
    Pisani, L.
    Ficicioglu, C.
    Giugliani, R.
    Harmatz, P.
    Rajan, D.
    Hagood, J.
    Fiscella, M.
    Yang, L.
    Wang, H.
    Gilmor, M.
    Cho, Y.
    Mulatya, C.
    Phillips, D.
    Falabella, P.
    ANNALS OF NEUROLOGY, 2023, 94 : S67 - S68
  • [3] RGX-121 gene therapy for the treatment of neuronopathic mucopolysaccharidosis type II (MPS II): Interim analysis of data from the first in human study
    Harmatz, Paul
    Ficicioglu, Can H.
    Giugliani, Roberto
    Rajan, Deepa
    Hagood, Joseph
    Fiscella, Michele
    Yang, Lin
    Gilmor, Michelle
    Cho, Yoonjin
    Phillips, Dawn
    Falabella, Paulo
    MOLECULAR GENETICS AND METABOLISM, 2023, 138 (02) : 57 - 57
  • [4] RGX-121 Gene Therapy for the Treatment of Severe Mucopolysaccharidosis Type II (MPS II): Interim Analysis of Data from the First in Human Study
    Ficicioglu, C.
    Escolar, M.
    Giugliani, R.
    Harmatz, P.
    Nevoret, M-L
    Fiscella, M.
    Yang, L.
    Cho, Y.
    Phillips, D.
    Falabella, P.
    ANNALS OF NEUROLOGY, 2021, 90 : S96 - S96
  • [5] RGX-121 Gene Therapy for the Treatment of Severe Mucopolysaccharidosis Type II (MPS II): Interim Analysis of Data from the First in Human Study
    GHiugliani, Roberto
    Escolar, Maria
    Ficicioglu, Can
    Harmatz, Paul
    Fiscella, Michele
    Yang, Lin
    Cho, Yoonjin
    Phillips, Dawn
    Falabella, Paulo
    MOLECULAR THERAPY, 2022, 30 (04) : 27 - 27
  • [6] CAMPSIITETM phase I/II/III: An interim clinical study update of RGX-121, an investigational gene therapy for the treatment of neuronopathic mucopolysaccharidosis type II (MPS II)
    Harmatz, Paul
    Ficicioglu, Can
    Giugliani, Roberto
    Rajan, Deepa
    Hagood, Joseph
    Fiscella, Michele
    Yang, Lin
    Gilmor, Michelle
    Cho, Yoonjin
    Mulatya, Caroline
    Phillips, Dawn
    Boulos, Nidal
    Falabella, Paulo
    Pisani, Laura
    MOLECULAR GENETICS AND METABOLISM, 2024, 141 (02)
  • [7] CAMPSIITET Phase I/II/III: An Interim Clinical Study Update of RGX-121, an Investigational Gene Therapy for the Treatment of Neuronopathic Mucopolysaccharidosis Type II (MPS II)
    Pisani, Laura
    Giugliani, Roberto
    Ficicioglu, Can
    Harmatz, Paul
    Rajan, Deepa
    Hagood, Joseph
    Fiscella, Michele
    Yang, Lin
    Gilmor, Michelle
    Cho, Yoonjin
    Mulatya, Caroline
    Phillips, Dawn
    Boulos, Nidal
    Falabella, Paulo
    MOLECULAR THERAPY, 2024, 32 (04) : 26 - 27
  • [8] CAMPSIITET Phase I/II/III: An interim clinical study update of RGX-121, an investigational gene therapy for the treatment of neuronopathic mucopolysaccharidosis type II (MPS II)
    Pisani, Laura
    Ficicioglu, Can
    Harmatz, Paul
    Giugliani, Roberto
    Rajan, Deepa
    Hagood, Joseph
    Fiscella, Michele
    Yang, Lin
    Gilmor, Michelle
    Cho, Yoonjin
    Mulatya, Caroline
    Phillips, Dawn
    Boulos, Nidal
    Falabella, Paulo
    MOLECULAR GENETICS AND METABOLISM, 2024, 141 (04)
  • [9] RGX-121 Gene Therapy for the Treatment of Severe Mucopolysaccharidosis Type II: Interim Analysis of the First in Human Study
    Giugliani, Roberto
    Escolar, Maria
    Ficicioglu, Can
    Harmatz, Paul
    Nevoret, Marie-Laure
    Cho, Yoonjin
    Phillips, Dawn
    Falabella, Paulo
    MOLECULAR THERAPY, 2021, 29 (04) : 112 - 113
  • [10] RGX-121 gene therapy for the treatment of severe mucopolysaccharidosis type II (MPS II): Interim analysis of data from a Phase 1/2 study
    Harmatz, P.
    Giugliani, R.
    Escolar, M.
    Ficicioglu, C.
    Fiscella, M.
    Yang, L.
    Cho, Y.
    Falabella, P.
    ANNALS OF NEUROLOGY, 2022, 92 : S170 - S170
12345